Indrani Lall Franchini, EVP, Chief Compliance Officer at ALEXION PHARMACEUTICALS INC (ALXN), sold 2,918 shares at $116.31 ($339K) on 2018-02-08, disclosed to the SEC on 2018-02-08.
Open-market sale of $339k ALXN by EVP, Chief Compliance Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.31 | 1,459 | $170K | 50.0% |
| 2 | $116.31 | 1,459 | $170K | 50.0% |
| Total | $116.31 avg | 2,918 | $339K | 100% |
| Filing → |
| ALNY | SELL | 2023-04-10 | $735K | — | Filing → |
| ALNY | SELL | 2023-02-03 | $739K | — | Filing → |
| ALXN | SELL | 2020-06-09 | $1.4M | — | Filing → |